Literature DB >> 9183510

Relapse prevention treatment for cocaine dependence: group vs. individual format.

J M Schmitz1, L M Oswald, S D Jacks, T Rustin, H M Rhoades, J Grabowski.   

Abstract

To investigate the role of treatment modality in relapse prevention treatment, 32 cocaine-dependent subjects were randomly assigned by cohorts to group-based relapse prevention (G-RP) or individually based RP (I-RP). The two RP formats were identical in content, consisting of 12 outpatient treatment sessions over a 2-month period immediately following hospitalization. The proportion of subjects providing cocaine-free urines at the end of RP treatment did not differ between formats; however, G-RP subjects reported using cocaine on significantly fewer days during treatment, and experiencing fewer cocaine-related problems than did I-RP subjects. Follow-up data collected at 12 and 24 weeks' posttreatment revealed no significant differences between RP formats on any cocaine-use outcome measures. Regardless of therapy format. RP treatment was related to statistically significant and sustained improvements in other areas of psychosocial functioning, including addiction severity, coping, and craving for cocaine. The overall findings suggest that the efficacy of relapse prevention training is not limited by therapy format.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183510     DOI: 10.1016/s0306-4603(96)00047-0

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  9 in total

1.  Cost-effectiveness of individual versus group female-specific cognitive behavioral therapy for alcohol use disorder.

Authors:  Todd A Olmstead; Fiona S Graff; Alyssa Ames-Sikora; Barbara S McCrady; Ayorkor Gaba; Elizabeth E Epstein
Journal:  J Subst Abuse Treat       Date:  2019-02-07

Review 2.  How effective is continuing care for substance use disorders? A meta-analytic review.

Authors:  Janet C Blodgett; Natalya C Maisel; Ingrid L Fuh; Paula L Wilbourne; John W Finney
Journal:  J Subst Abuse Treat       Date:  2013-09-26

3.  Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial.

Authors:  Joy M Schmitz; Marc E Mooney; Charles E Green; Scott D Lane; Joel L Steinberg; Alan C Swann; F Gerard Moeller
Journal:  J Addict Dis       Date:  2009-07

4.  Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

Authors:  Joy M Schmitz; Marc E Mooney; F Gerard Moeller; Angela L Stotts; Charles Green; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2007-12-27       Impact factor: 4.492

5.  High-dose naltrexone therapy for cocaine-alcohol dependence.

Authors:  Joy M Schmitz; Jan A Lindsay; Charles E Green; David V Herin; Angela L Stotts; F Gerard Moeller
Journal:  Am J Addict       Date:  2009 Sep-Oct

Review 6.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

7.  Individual versus group female-specific cognitive behavior therapy for alcohol use disorder.

Authors:  Elizabeth E Epstein; Barbara S McCrady; Kevin A Hallgren; Ayorkor Gaba; Sharon Cook; Noelle Jensen; Thomas Hildebrandt; Cathryn Glanton Holzhauer; Mark D Litt
Journal:  J Subst Abuse Treat       Date:  2018-02-22

8.  Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial.

Authors:  Elias Dakwar; Frances R Levin
Journal:  Am J Addict       Date:  2013-08-30

Review 9.  Continuing care research: what we have learned and where we are going.

Authors:  James R McKay
Journal:  J Subst Abuse Treat       Date:  2009-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.